Raymond J. Dingledine, Ph.D., is Professor and Chair of the Department of Pharmacology at Emory University School of Medicine and one of NeurOp’s founders. Prior to joining Emory in 1992, Dr. Dingledine was a professor in the Department of Pharmacology at the University of North Carolina, Chapel Hill. He is widely recognized as one of the foremost experts in the field of neuropharmacology, and his current research primarily focuses on the role of inflammation in disease indications involving seizures. He has published more than 200 research papers during his career and served as editor of Molecular Pharmacology. Dr. Dingledine was elected to the Institute of Medicine in 2010 and is the recipient of numerous other scientific honors and awards, including a Javits Neuroscience Investigator Award from the NIH, the Epilepsy Research Award from the American Epilepsy Society, two Bristol-Myers Squibb Neuroscience Awards, and the PhRMA Career Excellence Award. He is past treasurer of the Society for Neuroscience (SfN) and served on the scientific council of NINDS. He currently chairs the SfN Investment Committee and the Epilepsy Benchmarks Committee, a group charged with helping to set the national research agenda in epilepsy. Dr. Dingledine received his Ph.D. degree in pharmacology from Stanford University.

neuropharmacology